Free Trial

Freestone Grove Partners LP Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Acadia Healthcare logo with Medical background

Freestone Grove Partners LP purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 755,178 shares of the company's stock, valued at approximately $29,943,000. Freestone Grove Partners LP owned about 0.81% of Acadia Healthcare at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Lindbrook Capital LLC raised its stake in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after acquiring an additional 671 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the period. Nisa Investment Advisors LLC increased its holdings in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares during the period. Signaturefd LLC raised its position in Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares during the period.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Royal Bank of Canada lowered their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Barclays lowered shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $43.00 to $35.00 in a report on Friday, February 28th. KeyCorp dropped their price target on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. Finally, Mizuho cut their price target on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $50.39.

View Our Latest Report on Acadia Healthcare

Acadia Healthcare Price Performance

ACHC traded down $0.50 on Monday, hitting $22.81. 1,499,541 shares of the company's stock were exchanged, compared to its average volume of 1,624,409. The firm has a 50-day moving average price of $27.61 and a 200-day moving average price of $37.30. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 7.48, a P/E/G ratio of 1.46 and a beta of 1.01. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a fifty-two week low of $20.36 and a fifty-two week high of $82.41.

Acadia Healthcare Company Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines